Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Meitheal Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Meitheal Pharmaceuticals, Inc. with status Current. The shortage was first posted on Apr 10, 2021.

Shortage details

Status
Current
Company
Meitheal Pharmaceuticals, Inc.
Package NDC
71288-505-03
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)
Initial Posting
Apr 10, 2021

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.